• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激光诱导猪实验性视网膜静脉阻塞模型:一种优化的可重复方法。

Laser-Induced Porcine Model of Experimental Retinal Vein Occlusion: An Optimized Reproducible Approach.

机构信息

Department of Ophthalmology, Aalborg University Hospital, 9000 Aalborg, Denmark.

Department of Clinical Biochemistry, Aalborg University Hospital, 9000 Aalborg, Denmark.

出版信息

Medicina (Kaunas). 2023 Jan 27;59(2):243. doi: 10.3390/medicina59020243.

DOI:10.3390/medicina59020243
PMID:36837445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9962108/
Abstract

Retinal vein occlusion (RVO) is a frequent visually disabling condition. The management of RVO continues to challenge clinicians. Macular edema secondary to RVO is often recurrent, and patients typically require intravitreal injections for several years. Understanding molecular mechanisms in RVO is a key element in improving the treatment of the condition. Studying the molecular mechanisms in RVO at the retinal level is possible using animal models of experimental RVO. Most studies of experimental RVO have been sporadic, using only a few animals per experiment. Here, we report on 10 years of experience of the use of argon laser-induced experimental RVO in 108 porcine eyes from 65 animals, including 65 eyes with experimental branch retinal vein occlusion (BRVO) and 43 eyes with experimental central retinal vein occlusion (CRVO). Reproducibility and methods for evaluating and controlling ischemia in experimental RVO are reviewed. Methods for studying protein changes in RVO are discussed in detail, including proteomic analysis, Western blotting, and immunohistochemistry. Experimental RVO has brought significant insights into molecular changes in RVO. Testing intravitreal interventions in experimental RVO may be a significant step in developing personalized therapeutic approaches for patients with RVO.

摘要

视网膜静脉阻塞(RVO)是一种常见的致盲性疾病。RVO 的治疗仍然是临床医生面临的挑战。继发于 RVO 的黄斑水肿通常反复发作,患者通常需要数年的玻璃体腔内注射治疗。了解 RVO 中的分子机制是改善该疾病治疗的关键要素。使用实验性 RVO 的动物模型可以在视网膜水平上研究 RVO 的分子机制。大多数实验性 RVO 的研究都是零星的,每个实验仅使用少数几只动物。在这里,我们报告了使用氩激光诱导的实验性 RVO 在 65 只动物的 108 只猪眼中进行了 10 年的经验,包括 65 只实验性分支视网膜静脉阻塞(BRVO)和 43 只实验性中央视网膜静脉阻塞(CRVO)。我们回顾了评估和控制实验性 RVO 缺血的重现性和方法。详细讨论了研究 RVO 中蛋白质变化的方法,包括蛋白质组学分析、Western 印迹和免疫组织化学。实验性 RVO 为 RVO 中的分子变化带来了重要的见解。在实验性 RVO 中测试玻璃体腔内干预措施可能是为 RVO 患者开发个性化治疗方法的重要步骤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/bc7e37d38b82/medicina-59-00243-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/578775469ff4/medicina-59-00243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/5f82dcc31f26/medicina-59-00243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/5ae81d2183c3/medicina-59-00243-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/68925cb69e2f/medicina-59-00243-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/bc7e37d38b82/medicina-59-00243-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/578775469ff4/medicina-59-00243-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/5f82dcc31f26/medicina-59-00243-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/5ae81d2183c3/medicina-59-00243-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/68925cb69e2f/medicina-59-00243-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04e0/9962108/bc7e37d38b82/medicina-59-00243-g005.jpg

相似文献

1
Laser-Induced Porcine Model of Experimental Retinal Vein Occlusion: An Optimized Reproducible Approach.激光诱导猪实验性视网膜静脉阻塞模型:一种优化的可重复方法。
Medicina (Kaunas). 2023 Jan 27;59(2):243. doi: 10.3390/medicina59020243.
2
Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.在未经治疗的视网膜静脉阻塞所致黄斑水肿患者中使用两个或更多地塞米松玻璃体内植入物:一项回顾性病历审查研究的亚组分析
BMC Ophthalmol. 2015 Sep 4;15:118. doi: 10.1186/s12886-015-0106-z.
3
Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France.在法国临床环境中,地塞米松玻璃体内植入物用于治疗视网膜静脉阻塞继发黄斑水肿的两年前瞻性多中心研究。
Graefes Arch Clin Exp Ophthalmol. 2016 Dec;254(12):2307-2318. doi: 10.1007/s00417-016-3394-y. Epub 2016 Jun 11.
4
Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜静脉阻塞继发黄斑水肿后对视网膜中央的临床、解剖学及电生理评估
Int Ophthalmol. 2016 Feb;36(1):21-36. doi: 10.1007/s10792-015-0066-6. Epub 2015 Mar 29.
5
IL-18 and S100A12 Are Upregulated in Experimental Central Retinal Vein Occlusion.白细胞介素 18 和 S100A12 在实验性中心性视网膜静脉阻塞中上调。
Int J Mol Sci. 2018 Oct 25;19(11):3328. doi: 10.3390/ijms19113328.
6
"Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.玻璃体内注射贝伐单抗在视网膜静脉阻塞继发的非缺血性黄斑水肿中的“超说明书”使用。
Rom J Ophthalmol. 2016 Apr-Jun;60(2):90-95.
7
The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.血清炎症因子在抗血管内皮生长因子治疗视网膜静脉阻塞及其亚型所致黄斑水肿中的作用。
Ophthalmic Res. 2021;64(2):237-245. doi: 10.1159/000509171. Epub 2020 Jun 5.
8
Animal Models of Retinal Vein Occlusion.视网膜静脉阻塞的动物模型
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6175-6192. doi: 10.1167/iovs.17-22788.
9
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.玻璃体内注射地塞米松治疗视网膜静脉阻塞:一项前瞻性多中心临床试验的真实世界数据
Graefes Arch Clin Exp Ophthalmol. 2017 Jan;255(1):77-87. doi: 10.1007/s00417-016-3431-x. Epub 2016 Jul 26.
10
Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.视网膜内层紊乱与抗血管内皮生长因子治疗视网膜静脉阻塞继发黄斑水肿的视力反应的相关性研究。
JAMA Ophthalmol. 2019 Jan 1;137(1):38-46. doi: 10.1001/jamaophthalmol.2018.4484.

引用本文的文献

1
Complement C3 is downregulated following ranibizumab intervention in experimental central retinal vein occlusion.在实验性视网膜中央静脉阻塞中,雷珠单抗干预后补体 C3 下调。
Mol Vis. 2024 Jul 2;30:268-277. eCollection 2024.
2
Cytokine Levels in Experimental Branch Retinal Vein Occlusion Treated With Either Bevacizumab or Triamcinolone Acetonide.实验性分支视网膜静脉阻塞中贝伐单抗或曲安奈德治疗的细胞因子水平。
Transl Vis Sci Technol. 2024 Jun 3;13(6):13. doi: 10.1167/tvst.13.6.13.
3
The 2023 Report on the Proteome from the HUPO Human Proteome Project.

本文引用的文献

1
Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion.地塞米松玻璃体内植入物在实验性视网膜中央静脉阻塞植入 8 周后在分子水平上具有活性。
Molecules. 2022 Sep 3;27(17):5687. doi: 10.3390/molecules27175687.
2
Proteome Analysis of Aflibercept Intervention in Experimental Central Retinal Vein Occlusion.阿柏西普干预实验性中心性视网膜静脉阻塞的蛋白质组分析。
Molecules. 2022 May 24;27(11):3360. doi: 10.3390/molecules27113360.
3
Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort study.
2023 年人类蛋白质组组织蛋白质组报告。
J Proteome Res. 2024 Feb 2;23(2):532-549. doi: 10.1021/acs.jproteome.3c00591. Epub 2024 Jan 17.
4
Proteome Analysis of Bevacizumab Intervention in Experimental Central Retinal Vein Occlusion.贝伐单抗干预实验性视网膜中央静脉阻塞的蛋白质组学分析
J Pers Med. 2023 Nov 7;13(11):1580. doi: 10.3390/jpm13111580.
视网膜静脉阻塞患者的心血管发病率和全因死亡率:一项丹麦全国队列研究。
Br J Ophthalmol. 2023 Sep;107(9):1324-1330. doi: 10.1136/bjophthalmol-2022-321225. Epub 2022 May 10.
4
Proteomic analysis of vitreous humour of eyes with diabetic macular oedema: a systematic review.糖尿病性黄斑水肿患者玻璃体液的蛋白质组学分析:系统评价。
Acta Ophthalmol. 2022 Aug;100(5):e1043-e1051. doi: 10.1111/aos.15168. Epub 2022 May 4.
5
Retinal vein occlusion (RVO) guideline: executive summary.视网膜静脉阻塞(RVO)指南:执行摘要。
Eye (Lond). 2022 May;36(5):909-912. doi: 10.1038/s41433-022-02007-4. Epub 2022 Mar 17.
6
RNAi-mediated suppression of vimentin or glial fibrillary acidic protein prevents the establishment of Müller glial cell hypertrophy in progressive retinal degeneration.RNAi 介导的波形蛋白或神经胶质纤维酸性蛋白抑制可防止进行性视网膜变性中 Müller 胶质细胞肥大的建立。
Glia. 2021 Sep;69(9):2272-2290. doi: 10.1002/glia.24034. Epub 2021 May 24.
7
Aflibercept Intervention in Experimental Branch Retinal Vein Occlusion Results in Upregulation of DnaJ Homolog Subfamily C Member 17.阿柏西普干预实验性视网膜分支静脉阻塞导致DnaJ同源亚家族C成员17上调。
J Ophthalmol. 2021 Mar 6;2021:6690260. doi: 10.1155/2021/6690260. eCollection 2021.
8
An experimental pig model with outer retinal degeneration induced by temporary intravitreal loading of N-methyl-N-nitrosourea during vitrectomy.玻璃体切割术中临时玻璃体内注射 N-甲基-N-亚硝脲诱导的外视网膜变性实验猪模型。
Sci Rep. 2021 Jan 8;11(1):258. doi: 10.1038/s41598-020-79437-1.
9
Retinal Microcirculation and Cytokines as Predictors for Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Branch Retinal Vein Occlusion.视网膜微循环与细胞因子作为视网膜分支静脉阻塞患者玻璃体内注射雷珠单抗后黄斑水肿复发的预测指标
J Clin Med. 2020 Dec 26;10(1):58. doi: 10.3390/jcm10010058.
10
Aqueous Fibronectin Correlates With Severity of Macular Edema and Visual Acuity in Patients With Branch Retinal Vein Occlusion: A Proteome Study.房水纤维连接蛋白与分支型视网膜静脉阻塞患者黄斑水肿严重程度和视力的相关性:一项蛋白质组学研究。
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):6. doi: 10.1167/iovs.61.14.6.